Analysis of Radiographic and Kinematic Features in FAI Patients

NCT ID: NCT05867069

Last Updated: 2023-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

93 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2022-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to describe the radiographic and kinematic features in patients with femoroacetabular impingement syndrome (FAI). The main questions it aims to answer are:

* Is structural knee abnormalities associated with knee pain symptoms in FAI patients?
* Does FAI patients with knee pain demonstrate unique kinematic characteristics? Participants will receive routine preoperative radiographic examinations, which include ipsilateral knee MRI for the purpose of femoral version measurement. Participants will also receive markerless motion capture analysis.

Researchers will compare preoperative radiographic and kinematic features based on knee pain status, which is routinely collected as part of clinical investigation procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This observational study aims to study the association between preoperative subjective knee pain and baseline knee radiographic and kinematic characteristics. MRI of the ipsilateral knee is screened for structural abnormalities, including cartilage defects, meniscal tears and ligament injuries. Markerless motion capture data are evaluated for transverse plane kinematic features, with a primary focus on foot progression angles during normal gait.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoro Acetabular Impingement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ipsilateral knee pain group

Those FAI patients presenting with preoperative ipsilateral knee pain.

No interventions assigned to this group

No ipsilateral knee pain group

Those FAI patients presenting without preoperative ipsilateral knee pain.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* (1) diagnosed with FAI based on clinical and radiographical findings;
* (2) failed conservative treatment for at least 6 months and indicated for surgical treatment;
* (3) received routine preoperative hip and ipsilateral knee MRI.

Exclusion Criteria

* (1) history of fracture or surgery of hip and knee;
* (2) avascular necrosis;
* (3) Legg-Calve-Perthes disease;
* (4) Ehlers-Danlos syndrome;
* (5) pigmented villonodular synovitis (PVNS);
* (6) osteoid osteoma (OO);
* (7) synovial chondromatosis;
* (8) severe hip osteoarthritis (OA) with Tönnis grade \> 1;
* (9) developmental dysplasia of hip (DDH)
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University Third Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yan Xu, M.D.

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking University Third Hospital

Beijing, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S2021436

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.